Michael Fralick1, Jerry Avorn1, Aaron S Kesselheim1. 1. From the Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston (M.F., J.A., A.S.K.); and the University of Toronto Clinician-Scientist Training Program, Toronto (M.F.).
Authors: Francesco Trotta; Flavia Mayer; Francesco Barone-Adesi; Immacolata Esposito; Ranadhir Punreddy; Roberto Da Cas; Giuseppe Traversa; Francesco Perrone; Nello Martini; Bishal Gyawali; Antonio Addis Journal: BMJ Open Date: 2019-12-10 Impact factor: 2.692